← Back to Search

Behavioral Intervention

Medication Action Plan and Patient Empowerment (MAP-PE ) for Fall Injury (MEDS Trial)

N/A

Recruiting

Led By Carri Casteel, MPH, PhD

Research Sponsored by University of Iowa

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

MEDS Trial Summary

This trial will study how a medication care plan, grounded in established medication deprescribing and tapering frameworks, can be implemented in primary care clinics to reduce medically-treated falls among older adults living in rural Iowa communities.

Eligible Conditions

Fall Injury
Aging

MEDS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Frequency of Self-reported Falls (intervention vs control group)

Secondary outcome measures

3. Frequency of Traffic-Related Charges (intervention vs control group)

Frequency of Medically Treated Falls using EMR (intervention vs control group)

Frequency of Motor Vehicle Crashes (intervention vs control group)

MEDS Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Patients will receive a medication action plan approved by themselves and their primary care providers to reduce their medications. They will also receive check in calls and follow ups from study health coaches to monitor their progress. During health coaching sessions motivational interviewing techniques and patient empowerment strategies will be used by trained health coaches. Participants will also participate in assessments for the study (baseline and quarterly follow ups) and will complete up to 12 months of falls calendars.

Group II: ControlActive Control1 Intervention

Will participate in assessments for the study (baseline and quarterly follow ups) and will complete up to 12 months of falls calendars. No intervention will be given to this group, but standard practices of care delivered by the MercyOneSM Health Network.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Centers for Disease Control and PreventionFED

875 Previous Clinical Trials

22,477,004 Total Patients Enrolled

University of IowaLead Sponsor

446 Previous Clinical Trials

879,104 Total Patients Enrolled

Carri Casteel, MPH, PhDPrincipal InvestigatorUniversity of Iowa

Media Library

Medication Action Plan and Patient Empowerment (MAP-PE) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04612166 — N/A

Fall Injury Research Study Groups: Intervention, Control

Fall Injury Clinical Trial 2023: Medication Action Plan and Patient Empowerment (MAP-PE) Highlights & Side Effects. Trial Name: NCT04612166 — N/A

Medication Action Plan and Patient Empowerment (MAP-PE) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04612166 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many candidates will be enrolled in this clinical trial?

"Affirmative. Information published on clinicaltrials.gov confirms that this research endeavour, initiated on August 1st 2020, is presently recruiting participants. With the goal of enrolling 370 individuals at one site in mind."

Answered by AI

To whom does the eligibility for this experiment extend?

"This medical trial is seeking 370 people aged 65 to 110 who have existing wounds and meet the following criteria: Fluency in English, answering affirmatively to one or more of three questions on stability when standing/walking, living independently without caretakers, and being prescribed medications which increase risk for falling (opioids, benzodiazepines, anticholinergics)."

Answered by AI

Are participants above the age of 80 precluded from this investigational trial?

"This medical trial has an age range of 65 to 110 years old. There are 123 studies for young patients and 834 for elderly individuals who meet the inclusion criteria."

Answered by AI

Are there any vacancies to participate in this experiment?

"As per the information on clinicaltrials.gov, this medical experiment is currently seeking participants and was initially publicized on August 1st 2020 with a recent update made in September of 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Medication Empowerment and Deprescription for Safety (MEDS) Study

Carri Casteel 2020. "Medication Empowerment and Deprescription for Safety (MEDS) Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04612166.